Bayer

U.S. FDA accepts Bayer’s supplemental New Drug Application for finerenone in chronic kidney disease without diabetes

08 Oct 2026

Bayer to invest 2.2 billion U.S. dollars in a new manufacturing site in the United States

03 Oct 2026

Bayer appoints Dr. Christoph Koenen, MD, as Chief Medical Officer

01 Oct 2026

BlueRock Therapeutics’ investigational cell therapy lemiretprocel (OpCT-001) for primary photoreceptor diseases granted orphan drug designations by FDA and EMA

30 Sep 2026

Bayer Launches New Menopause Advocacy and Policy Alliance

29 Sep 2026

Bayer’s Lynkuet™ (elinzanetant) granted priority review by U.S. FDA for additional indication

29 Sep 2026

Bayer places 2 billion euro hybrid bonds

28 Sep 2026

Bayer launches mono-material PP blister for Talcid® in Germany

28 Sep 2026

Articles tagged with 'dermatology' | Bayer

28 Sep 2026

Robigo and Leaps by Bayer Announce Series A Financing to Advance Engineered Biologicals That Protect Yields and Reduce Costs

28 Sep 2026

View details about the software product Informachine News Trackers